CN121285557A - 喹啉取代化合物的晶体 - Google Patents

喹啉取代化合物的晶体

Info

Publication number
CN121285557A
CN121285557A CN202480036614.7A CN202480036614A CN121285557A CN 121285557 A CN121285557 A CN 121285557A CN 202480036614 A CN202480036614 A CN 202480036614A CN 121285557 A CN121285557 A CN 121285557A
Authority
CN
China
Prior art keywords
crystal
compound
crystals
quinolin
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480036614.7A
Other languages
English (en)
Chinese (zh)
Inventor
宇野贵夫
武田大典
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of CN121285557A publication Critical patent/CN121285557A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202480036614.7A 2023-05-31 2024-05-30 喹啉取代化合物的晶体 Pending CN121285557A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-090561 2023-05-31
JP2023090561 2023-05-31
PCT/JP2024/019849 WO2024248083A1 (ja) 2023-05-31 2024-05-30 キノリン置換化合物の結晶

Publications (1)

Publication Number Publication Date
CN121285557A true CN121285557A (zh) 2026-01-06

Family

ID=93658111

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480036614.7A Pending CN121285557A (zh) 2023-05-31 2024-05-30 喹啉取代化合物的晶体

Country Status (5)

Country Link
EP (1) EP4722218A1 (https=)
JP (1) JPWO2024248083A1 (https=)
CN (1) CN121285557A (https=)
TW (1) TW202502767A (https=)
WO (1) WO2024248083A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025141465A1 (en) 2023-12-27 2025-07-03 Assia Chemical Industries Ltd. Solid state forms of zipalertinib hydrochloride and process for preparation thereof
WO2025167588A1 (zh) * 2024-02-05 2025-08-14 苏州科睿思制药有限公司 Zipalertinib的晶型及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016003247B1 (pt) 2013-08-22 2022-05-10 Taiho Pharmaceutical Co., Ltd Composto substituído por quinolina, composição farmacêutica compreendendo o referido composto e seu uso
JP2018002644A (ja) * 2016-06-30 2018-01-11 大鵬薬品工業株式会社 （Ｓ）−Ｎ−（４−アミノ−５−（キノリン−３−イル）−６，７，８，９−テトラヒドロピリミド［５，４−ｂ］インドリジン−８−イル）アクリルアミドの結晶
WO2022121967A1 (zh) * 2020-12-09 2022-06-16 南京药石科技股份有限公司 Egfr酪氨酸激酶抑制剂及其用途
CN115707704B (zh) * 2021-08-20 2024-09-13 广东医诺维申生物技术有限公司 氘代稠合三环类化合物及其组合物和用途
JP2025538804A (ja) * 2022-12-08 2025-11-28 アッシア ケミカル インダストリーズ リミテッド ジパレルチニブの固体状態の形態及びそれを調製するための方法
CN115785107B (zh) * 2022-12-15 2024-11-12 南京雷正医药科技有限公司 一种取代8,9-二氢嘧啶并[5,4-b]吲嗪类化合物、药物组合物及其用途

Also Published As

Publication number Publication date
TW202502767A (zh) 2025-01-16
WO2024248083A1 (ja) 2024-12-05
JPWO2024248083A1 (https=) 2024-12-05
EP4722218A1 (en) 2026-04-08

Similar Documents

Publication Publication Date Title
CN121285557A (zh) 喹啉取代化合物的晶体
JP2022517396A (ja) Ｅｇｆｒ阻害剤の塩、結晶形及びその製造方法
TW202308991A (zh) 三苯化合物之固體形式
EP3394070A1 (en) Crystalline forms of quinolone analogs and their salts
WO2022022398A1 (zh) 一种嘧啶类化合物的盐和晶型及其制备方法
JP2023543055A (ja) テガビビントの結晶形態、調製方法、及びその使用
EP4512808A1 (en) Crystal of 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative
JP7391226B2 (ja) ピリミジン化合物の結晶
WO2026095022A1 (ja) キノリン置換化合物の結晶
CN105646461B (zh) S构型4-(取代苯胺基)喹唑啉衍生物及其制备方法和用途
JP7282787B2 (ja) ピラゾロ［３，４－ｄ］ピリミジンの結晶
US9611272B2 (en) Polymorphic forms of icotinib and uses thereof
CN106188017B (zh) R构型4-(取代苯胺基)喹唑啉衍生物及其制备方法和用途
AU2024320769A1 (en) Crystal form vi of acrylamide compound, and preparation method therefor and use thereof
HK40120602A (zh) 7h-吡咯并[2，3-d]嘧啶-4-胺衍生物的晶体
TWI596098B (zh) 埃克替尼馬來酸鹽的晶型及其用途
US20090247768A1 (en) Crystalline sulfonamide-containing indole compound and process for preparing the same
JP2025541841A (ja) オキソイソインドール－５－カルボキサミド系化合物またはその塩、溶媒和物の結晶形または無定形
CN120271606A (zh) 一种嘧啶并环化合物的盐、其晶型、其制备方法及应用
HK40041642A (en) Crystal of pyrazolo[3,4-d]pyrimidine
WO2024027565A1 (zh) 螺环胺类芳基磷氧化合物的晶型及其制备方法
HK40098923A (en) Crystalline forms of quinolone analogs and their salts
CN119263973A (zh) 蒽贝素的新晶型及其制备方法和用途
CN113956245A (zh) 克莱拉尼的晶型及其使用方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication